Revitope Oncology, Inc.

Oct 29, 2024

Revitope Enters into a License Agreement for Next-generation T Cell Engagement Technology

Feb 02, 2021

Revitope Oncology Appoints Biotech Industry Pioneer Louis Lange to its Board of Directors

Jan 05, 2021

Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform

Sep 16, 2020

Revitope Oncology Adds Carsten Reinhardt, a Pioneer of Modern Immunotherapy, to its Board of Directors

Jul 13, 2020

Revitope And Junshi Biosciences Enter Into Research Collaboration And License Agreement To Explore Next Generation Immunotherapies With Precision-Targeted T-Cell Engaging Antibodies